Laboratory test guide

GI-MAP® (GI Microbial Assay Plus)

Available through Diagnostic Solutions Laboratory

Optimal Health — It All Starts with the GI-MAP™Research overwhelmingly indicates that gut health impacts overall health. The gut microbiome, in particular, plays a critical role in mediating the effects of diet and other…

Compare this test’s laboratory options

GI-MAP Stool Testing

Diagnostic Solutions Laboratory
1 test optionFrom $687.08View tests ↓Close ↑

GI-MAP® (GI Microbial Assay Plus)

Diagnostic Solutions Laboratory

Details

Listed markers: Eosinophil Protein X; Roseburia spp.; Prevotella spp.; Klebsiella pneumoniae; Anti-Gliadin IgA; Taenia spp.; Chilomastix mesnili; Pancreatic Elastase 1; Faecalibacterium prausnitzii; Akkermansia muciniphila; Cryptosporidium spp.; Giardia; Lactobacillus spp.; Fusobacterium spp.; Bifidobacterium spp.; Beta-Glucuronidase; Trichuris trichiura; Entamoeba coli; Endolimax nana; Dientamoeba fragilis; Candida spp.; Ascaris lumbricoides; Helicobacter pylori; Necator americanus; Ancylostoma duodenale; Microsporidium spp.; Geotrichum spp.; Epstein-barr virus; Cyclospora spp.; Staphylococcus spp.; Enterococcus spp.; Escherichia spp.; Desulfovibrio spp.; Citrobacter spp.; Cytomegalovirus; Enterotoxigenic E. coli; Bacillus spp.; H. pylori antibiotic resistance genes; H. pylori virulence factor vird; Campylobacter spp.; Clostridium difficile toxin a; Clostridium difficile toxin b; Salmonella spp.; Shiga-like toxin E. coli stx1; Shiga-like toxin E. coli stx2; Steatocrit; Enterobacter spp.; Staphylococcus aureus; E. coli o157; Yersinia enterocolitica; Streptococcus spp.; Proteus mirabilis; Firmicutes/bacteroidetes ratio; Firmicutes; Enteroinvasive E. coli/Shigella; Blastocystis hominis; Bacteroidetes; Vibrio cholerae; Secretory IgA; Pentatrichomonas hominis; Norovirus GI/GII; Entamoeba histolytica; Adenovirus 40/41; Mycobacterium avium subsp. paratuberculosis; H. pylori virulence factor oipa; H. pylori virulence factor virb; Morganella spp.; Rhodotorula spp.; Methanobacteriaceae; Proteus spp.; Klebsiella spp.; Citrobacter freundii; Pseudomonas aeruginosa; Pseudomonas spp.; Enterococcus faecium; Enterococcus faecalis; Bacteroides fragilis; H. pylori virulence factor vaca; H. pylori virulence factor icea; H. pylori virulence factor dupa; H. pylori virulence factor caga; H. pylori virulence factor baba; Enterohemorrhagic E. coli; Calprotectin, Stool; Occult Blood, Stool; Candida albicans

Fasting: No

Results should arrive 7 - 14 business days after the lab receives samples.

Not available in: HI, PR, NJ, NY, RI

Related options may differ in markers and method; confirm with your clinician. Final prices and fees are confirmed before ordering.

SpecimenStool
Patient price$687.08
View →

What this laboratory test evaluates

Optimal Health — It All Starts with the GI-MAP™Research overwhelmingly indicates that gut health impacts overall health. The gut microbiome, in particular, plays a critical role in mediating the effects of diet and other factors on health, including digestive, immune, metabolic and neuroendocrine functions. Assessing GI health with the proper tools can help practitioners get to the root cause of chronic illness. The GI‑MAP (Microbial Assay Plus) is unique in the field of comprehensive stool testing. It relies exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more, by targeting the specific DNA of the organisms tested.

Why Is Quantification Using qPCR Technology So Important?Unlike other comprehensive stool tests on the market, the GI-MAP can provide practitioners with truly quantitative results. qPCR offers a much more accurate way to detect and quantify clinically-relevant organisms than standard PCR, culture, microscopy, or DNA sequencing-based methods. Accurately assessing how much of an organism's DNA is present in a patient's stool sample is essential for helping practitioners to determine the clinical significance of pathogenic organisms and dysbiosis patterns.

qPCR's Reliability, Reproducibility, and Use in Clinical ResearchAlthough qPCR is becoming more commonplace in in-vitro diagnostics (IVD), we are the only laboratory in the United States exclusively using qPCR technology for advanced comprehensive stool testing. This technology is used routinely in clinical and academic research because it provides highly-accurate quantification, as well as high levels of sensitivity and specificity. Standard PCR technology doesn't offer the same level of sensitivity, or the ability to express precise numerical results.

The GI-MAP also provides consistently reproducible results. Reproducibility is of crucial importance to the practitioners and patients that rely on the efficacy of the GI-MAP. To achieve it, we perform rigorous quality control, and have validated all molecular target quantification assays to meet or exceed FDA standards.

GI-MAP Allows for the Personalized Treatment Plans and Informative RetestsThe GI-MAP's accuracy and reliability allows practitioners to create personalized treatment protocols to address gut dysfunction based on which infections are urgent, which areas of the gut are already optimized, and which areas should be addressed after an infection is resolved.

Additionally, the quantification offers a remarkable ability to see how treatment modalities are working because a retest after treatment can show whether a parasite has resolved, dysbiosis has improved, and more.

Additional test information

Research overwhelmingly indicates that gut health impacts overall health. The gut microbiome plays a critical role in mediating the effects of diet, digestion, immunity, metabolic function, and more. This GI-MAP (Microbial Assay Plus) test is truly unique in the field – relying exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more by targeting the specific DNA of the organisms tested. The quantitative insights provided in this process, known for accuracy and reliability, allow practitioners to create more personalized treatment protocols for optimizing gut function and addressing dysfunction.

Collection and processing

  • Sample type: Stool
  • Fasting: No
  • Estimated laboratory processing: Results should arrive 7 – 14 business days after the lab receives samples.

How Sunridge uses laboratory information

Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.

Before requesting this test

Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.

Related Sunridge care

Learn how Sunridge approaches Digestive Conditions and ask whether this test is appropriate for your clinical question.

About this test

Optimal Health — It All Starts with the GI-MAP™Research overwhelmingly indicates that gut health impacts overall health. The gut microbiome, in particular, plays a critical role in mediating the effects of diet and other factors on health, including digestive, immune, metabolic and neuroendocrine functions. Assessing GI health with the proper tools can help practitioners get to the root cause of chronic illness. The GI‑MAP (Microbial Assay Plus) is unique in the field of comprehensive stool testing. It relies exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more, by targeting the specific DNA of the organisms tested.

Why Is Quantification Using qPCR Technology So Important?Unlike other comprehensive stool tests on the market, the GI-MAP can provide practitioners with truly quantitative results. qPCR offers a much more accurate way to detect and quantify clinically-relevant organisms than standard PCR, culture, microscopy, or DNA sequencing-based methods. Accurately assessing how much of an organism's DNA is present in a patient's stool sample is essential for helping practitioners to determine the clinical significance of pathogenic organisms and dysbiosis patterns.

qPCR's Reliability, Reproducibility, and Use in Clinical ResearchAlthough qPCR is becoming more commonplace in in-vitro diagnostics (IVD), we are the only laboratory in the United States exclusively using qPCR technology for advanced comprehensive stool testing. This technology is used routinely in clinical and academic research because it provides highly-accurate quantification, as well as high levels of sensitivity and specificity. Standard PCR technology doesn't offer the same level of sensitivity, or the ability to express precise numerical results.

The GI-MAP also provides consistently reproducible results. Reproducibility is of crucial importance to the practitioners and patients that rely on the efficacy of the GI-MAP. To achieve it, we perform rigorous quality control, and have validated all molecular target quantification assays to meet or exceed FDA standards.

GI-MAP Allows for the Personalized Treatment Plans and Informative RetestsThe GI-MAP's accuracy and reliability allows practitioners to create personalized treatment protocols to address gut dysfunction based on which infections are urgent, which areas of the gut are already optimized, and which areas should be addressed after an infection is resolved.

Additionally, the quantification offers a remarkable ability to see how treatment modalities are working because a retest after treatment can show whether a parasite has resolved, dysbiosis has improved, and more.

Additional details

Research overwhelmingly indicates that gut health impacts overall health. The gut microbiome plays a critical role in mediating the effects of diet, digestion, immunity, metabolic function, and more. This GI-MAP (Microbial Assay Plus) test is truly unique in the field – relying exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more by targeting the specific DNA of the organisms tested. The quantitative insights provided in this process, known for accuracy and reliability, allow practitioners to create more personalized treatment protocols for optimizing gut function and addressing dysfunction.

Highlighted health areas

  • Infectious Disease
  • Nutrition
  • Gastrointestinal

Biomarkers and report focus

The exact analytes and report format can change. Confirm the current contents in the Fullscript order before payment.

  • Eosinophil Protein X
  • Roseburia spp.
  • Prevotella spp.
  • Klebsiella pneumoniae
  • Anti-Gliadin IgA
  • Taenia spp.
  • Chilomastix mesnili
  • Pancreatic Elastase 1
  • Faecalibacterium prausnitzii
  • Akkermansia muciniphila
  • Cryptosporidium spp.
  • Giardia
  • Lactobacillus spp.
  • Fusobacterium spp.
  • Bifidobacterium spp.
  • Beta-Glucuronidase
  • Trichuris trichiura
  • Entamoeba coli
  • Endolimax nana
  • Dientamoeba fragilis
  • Candida spp.
  • Ascaris lumbricoides
  • Helicobacter pylori
  • Necator americanus
  • Ancylostoma duodenale
  • Microsporidium spp.
  • Geotrichum spp.
  • Epstein-barr virus
  • Cyclospora spp.
  • Staphylococcus spp.
View all 86 listed biomarkers
  • Enterococcus spp.
  • Escherichia spp.
  • Desulfovibrio spp.
  • Citrobacter spp.
  • Cytomegalovirus
  • Enterotoxigenic E. coli
  • Bacillus spp.
  • H. pylori antibiotic resistance genes
  • H. pylori virulence factor vird
  • Campylobacter spp.
  • Clostridium difficile toxin a
  • Clostridium difficile toxin b
  • Salmonella spp.
  • Shiga-like toxin E. coli stx1
  • Shiga-like toxin E. coli stx2
  • Steatocrit
  • Enterobacter spp.
  • Staphylococcus aureus
  • E. coli o157
  • Yersinia enterocolitica
  • Streptococcus spp.
  • Proteus mirabilis
  • Firmicutes/bacteroidetes ratio
  • Firmicutes
  • Enteroinvasive E. coli/Shigella
  • Blastocystis hominis
  • Bacteroidetes
  • Vibrio cholerae
  • Secretory IgA
  • Pentatrichomonas hominis
  • Norovirus GI/GII
  • Entamoeba histolytica
  • Adenovirus 40/41
  • Mycobacterium avium subsp. paratuberculosis
  • H. pylori virulence factor oipa
  • H. pylori virulence factor virb
  • Morganella spp.
  • Rhodotorula spp.
  • Methanobacteriaceae
  • Proteus spp.
  • Klebsiella spp.
  • Citrobacter freundii
  • Pseudomonas aeruginosa
  • Pseudomonas spp.
  • Enterococcus faecium
  • Enterococcus faecalis
  • Bacteroides fragilis
  • H. pylori virulence factor vaca
  • H. pylori virulence factor icea
  • H. pylori virulence factor dupa
  • H. pylori virulence factor caga
  • H. pylori virulence factor baba
  • Enterohemorrhagic E. coli
  • Calprotectin, Stool
  • Occult Blood, Stool
  • Candida albicans

Important laboratory-testing information

This article is educational and does not diagnose a condition, establish medical care, or replace professional advice. Test availability, contents, pricing, eligibility, specimen instructions, and processing estimates can change. Sunridge must review the request and create an appropriate Fullscript order before payment. Follow the current instructions in your Fullscript account and laboratory kit, and discuss urgent or worsening symptoms with an appropriate medical professional.

Scottsdale Clinic

14200 N Northsight Blvd #160
Scottsdale, Arizona 85260

Office Hours

Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM

Visit Sunridge in Scottsdale

FREE INTRODUCTORY CALL

Speak With Our Patient Care Team

Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.

Call Now: 1-800-923-7878

This introductory call is not a medical consultation and does not establish a physician-patient relationship.

Have a Question or Share Feedback:
It's easy to get in touch with us